Écrit par ANSM | 24 Août 2016

Information destinée aux oncologues, hématologues et pharmaciens hospitaliersLes professionnels de santé ont été informés des résultats de la réévaluation des données de sécurité concernant l'utilisation de Zydelig (idelalisib).

L'indication d'idelalisib en traitement de première intention chez les patients atteints de leucémie lymphoïde chronique (LLC) est désormais la...

Écrit par Afrorgocommunications | 24 Août 2016

Brazzaville, 22 August 2016 – Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and products promote drug resistance and lead to loss of confidence in health professionals, pharmaceutical manufacturers and distributors and in health...

Écrit par WHO | 24 Août 2016

22 August 2016 | GENEVA - A WHO emergency health team arrived 19 August 2016 in Maiduguri State to assess and respond to the health needs of 800 000 people in north eastern Nigeria, formerly held by militant insurgency groups. WHO is scaling up its emergency response activities, together with partners, to assist hundreds of thousands of people in desperate need of health services. More than...

Écrit par Philips | 24 Août 2016

JOHANNESBURG, South Africa, August 22, 2016/ -- Around the globe, disruption, innovation, and the rapid pace of technological development is reshaping consumer experience, as well as the operating environment for organisations of all sizes and within every industry. The healthcare industry is no exception. Today, technological and business innovation is empowering companies and healthcare...